BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 10410981)

  • 1. Development of a sensitive enzyme-linked immunosorbent assay for eotaxin and measurement of its levels in human blood.
    Morita A; Shimosako K; Kikuoka S; Taniguchi Y; Kitaura M; Sasakura K; Tamaki M; Tsuji T; Teraoka H; Yoshie O; Nakajima T; Hirai K
    J Immunol Methods; 1999 Jun; 226(1-2):159-67. PubMed ID: 10410981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased plasma eotaxin in atopic dermatitis and acute urticaria in infants and children.
    Hossny E; Aboul-Magd M; Bakr S
    Allergy; 2001 Oct; 56(10):996-1002. PubMed ID: 11576081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cloning of the human eosinophil chemoattractant, eotaxin. Expression, receptor binding, and functional properties suggest a mechanism for the selective recruitment of eosinophils.
    Ponath PD; Qin S; Ringler DJ; Clark-Lewis I; Wang J; Kassam N; Smith H; Shi X; Gonzalo JA; Newman W; Gutierrez-Ramos JC; Mackay CR
    J Clin Invest; 1996 Feb; 97(3):604-12. PubMed ID: 8609214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Migration of eosinophils across endothelial cell monolayers: interactions among IL-5, endothelial-activating cytokines, and C-C chemokines.
    Shahabuddin S; Ponath P; Schleimer RP
    J Immunol; 2000 Apr; 164(7):3847-54. PubMed ID: 10725746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential regulation of epithelial-derived C-C chemokine expression by IL-4 and the glucocorticoid budesonide.
    Stellato C; Matsukura S; Fal A; White J; Beck LA; Proud D; Schleimer RP
    J Immunol; 1999 Nov; 163(10):5624-32. PubMed ID: 10553092
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Eosinophils in the human corpus luteum: the role of RANTES and eotaxin in eosinophil attraction into periovulatory structures.
    Aust G; Simchen C; Heider U; Hmeidan FA; Blumenauer V; Spanel-Borowski K
    Mol Hum Reprod; 2000 Dec; 6(12):1085-91. PubMed ID: 11101691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intracellular localization and release of eotaxin from normal eosinophils.
    Nakajima T; Yamada H; Iikura M; Miyamasu M; Izumi S; Shida H; Ohta K; Imai T; Yoshie O; Mochizuki M; Schröder JM; Morita Y; Yamamoto K; Hirai K
    FEBS Lett; 1998 Sep; 434(3):226-30. PubMed ID: 9742928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated plasma eotaxin levels in patients with acute asthma.
    Lilly CM; Woodruff PG; Camargo CA; Nakamura H; Drazen JM; Nadel ES; Hanrahan JP
    J Allergy Clin Immunol; 1999 Oct; 104(4 Pt 1):786-90. PubMed ID: 10518822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of plasma eotaxin levels with the presence and extent of angiographic coronary artery disease.
    Emanuele E; Falcone C; D'Angelo A; Minoretti P; Buzzi MP; Bertona M; Geroldi D
    Atherosclerosis; 2006 May; 186(1):140-5. PubMed ID: 16084515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Eotaxin levels in pleural effusions: comparison with monocyte chemoattractant protein-1 and IL-8.
    Yokoyama A; Kohno N; Ito M; Abe M; Hiwada K; Yamada H; Matsushima K; Hirai K
    Intern Med; 2000 Jul; 39(7):547-52. PubMed ID: 10888210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular cloning and characterization of a human eotaxin receptor expressed selectively on eosinophils.
    Ponath PD; Qin S; Post TW; Wang J; Wu L; Gerard NP; Newman W; Gerard C; Mackay CR
    J Exp Med; 1996 Jun; 183(6):2437-48. PubMed ID: 8676064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Eotaxin is required for the baseline level of tissue eosinophils.
    Matthews AN; Friend DS; Zimmermann N; Sarafi MN; Luster AD; Pearlman E; Wert SE; Rothenberg ME
    Proc Natl Acad Sci U S A; 1998 May; 95(11):6273-8. PubMed ID: 9600955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human eotaxin represents a potent activator of the respiratory burst of human eosinophils.
    Elsner J; Höchstetter R; Kimmig D; Kapp A
    Eur J Immunol; 1996 Aug; 26(8):1919-25. PubMed ID: 8765040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased serum levels of eotaxin in patients with inflammatory bowel disease.
    Chen W; Paulus B; Shu D; Wilson ; Chadwick V
    Scand J Gastroenterol; 2001 May; 36(5):515-20. PubMed ID: 11346206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for increased expression of eotaxin and monocyte chemotactic protein-4 in atopic dermatitis.
    Taha RA; Minshall EM; Leung DY; Boguniewicz M; Luster A; Muro S; Toda M; Hamid QA
    J Allergy Clin Immunol; 2000 May; 105(5):1002-7. PubMed ID: 10808183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Eotaxin triggers eosinophil-selective chemotaxis and calcium flux via a distinct receptor and induces pulmonary eosinophilia in the presence of interleukin 5 in mice.
    Rothenberg ME; Ownbey R; Mehlhop PD; Loiselle PM; van de Rijn M; Bonventre JV; Oettgen HC; Leder P; Luster AD
    Mol Med; 1996 May; 2(3):334-48. PubMed ID: 8784786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Th2- and to a lesser extent Th1-type cytokines upregulate the production of both CXC (IL-8 and gro-alpha) and CC (RANTES, eotaxin, eotaxin-2, MCP-3 and MCP-4) chemokines in human airway epithelial cells.
    Meyer-Hoffert U; Lezcano-Meza D; Bartels J; Montes-Vizuet AR; Schröder JM; Teran LM
    Int Arch Allergy Immunol; 2003 Aug; 131(4):264-71. PubMed ID: 12915769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cloning and functional characterization of a novel human CC chemokine that binds to the CCR3 receptor and activates human eosinophils.
    White JR; Imburgia C; Dul E; Appelbaum E; O'Donnell K; O'Shannessy DJ; Brawner M; Fornwald J; Adamou J; Elshourbagy NA; Kaiser K; Foley JJ; Schmidt DB; Johanson K; Macphee C; Moores K; McNulty D; Scott GF; Schleimer RP; Sarau HM
    J Leukoc Biol; 1997 Nov; 62(5):667-75. PubMed ID: 9365122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. C-C chemokines in allergen-induced late-phase cutaneous responses in atopic subjects: association of eotaxin with early 6-hour eosinophils, and of eotaxin-2 and monocyte chemoattractant protein-4 with the later 24-hour tissue eosinophilia, and relationship to basophils and other C-C chemokines (monocyte chemoattractant protein-3 and RANTES).
    Ying S; Robinson DS; Meng Q; Barata LT; McEuen AR; Buckley MG; Walls AF; Askenase PW; Kay AB
    J Immunol; 1999 Oct; 163(7):3976-84. PubMed ID: 10491000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of chemokine CCR3 agonist-mediated eosinophil recruitment in the Brown-Norway rat.
    Kudlacz EM; Whitney CA; Andresen CJ; Umland JP; Cheng JB
    Br J Pharmacol; 1999 Oct; 128(3):788-94. PubMed ID: 10516663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.